White label ELPA - ClinicalTrials.eu

Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor in Children and Adults with Cystic Fibrosis Aged 2 Years and Older

Not recruiting

3 1 1 1
Investigated diseases:
- Cystic fibrosis
Investigated drugs:
Study on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies

Not recruiting

1 1 1 1
Investigated drugs:
- Delandistrogene Moxeparvovec
- Imlifidase
Study Comparing Diclofenac and Thiocolchicoside Injection to Diclofenac Alone for Patients with Acute Moderate to Severe Low Back Pain

Not recruiting

3 1 1 1
Investigated diseases:
- Back pain
Investigated drugs:
- Diclofenac Sodium
- Thiocolchicoside
Study on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial

Not recruiting

3 1 1
Investigated diseases:
- Cardiac amyloidosis
Investigated drugs:
- Acoramidis Hydrochloride
+3
Study on Pembrolizumab and Olaparib for Patients with Resectable Soft Tissue Sarcoma

Not recruiting

2 1 1 1
Investigated diseases:
- Dedifferentiated liposarcoma
- Malignant fibrous histiocytoma
Investigated drugs:
- Olaparib
- Pembrolizumab
Study of Fibrinogen Treatment for Bleeding in Patients with Blood Cancer and Low Platelet Count Who Do Not Respond to Platelet Transfusions

Not recruiting

2 1 1 1
Investigated diseases:
- Haematological malignancy
Investigated drugs:
- Human Fibrinogen
Study on the Safety and Effectiveness of BOOST Cells for Treating Severe Osteogenesis Imperfecta in Children Before and After Birth

Not recruiting

1 1 1
Investigated diseases:
- Osteogenesis imperfecta
Investigated drugs:
- Allogeneic Fetal Mesenchymal Stem Cells
Study on Allergenic Extracts of Mites and Histamine Dihydrochloride for Allergy Patients

Not recruiting

2 1 1
Investigated diseases:
- Hypersensitivity
Investigated drugs:
Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
+3
Title: Study of everolimus with hormone therapy in women with high-risk breast cancer (ER-positive, HER2-negative) who are disease-free after initial treatment

Not recruiting

3 1 1
Investigated diseases:
- Hormone receptor positive HER2 negative breast cancer
Investigated drugs:
- Placebo
- Everolimus

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies